Acutaas Chemicals Limited (formerly Ami Organics Limited) has released the transcript of its earnings conference call for the third quarter and nine months ended December 31, 2025. The call, held on January 28, 2026, featured management including Chairman and Managing Director Mr. Naresh Patel, Vice President of Strategy Mr. Abhishek Patel, and Chief Financial Officer Mr. Bhavin Shah. During the call, the management discussed the company's strategic initiatives, including growth in pharmaceutical intermediates, the new battery chemicals business with a recently inaugurated facility at Jhagadia, and early-stage semiconductor chemicals business through joint ventures in South Korea. They highlighted that by FY2028, these three verticals are expected to operate as independent, self-sustaining growth engines. Financial performance for Q3 FY26 showed revenue from operations close to ₹400 crores with record margins, leading to a profit after tax exceeding ₹100 crores. The company revised its revenue guidance upwards to approximately 30% growth for FY26 and upgraded its EBITDA margin guidance for the full year to 32%-35% from 28%-30%. For the nine months of FY26, revenue was ₹906.6 crores, with EBITDA doubling and PAT more than doubling compared to the previous year. Discussions also covered the performance of the Advanced Pharmaceutical Intermediates segment (revenue of ₹351.1 crores in Q3 FY26, up 47.0% YoY) and the Specialty Chemicals segment (revenue of ₹42.1 crores, up 16.5% YoY). Capital expenditure for the nine-month period was ₹143 crores, mainly for the battery chemical project and a pilot plant. The company also noted that its CMD, Mr. Naresh Patel, was recognized among Hurun India's Top 200 Self-made Entrepreneurs.
